Interestingly, TPX2 is also known to interact with the mitotic kinase Aurora A, and the sensitivity of non-Hodgkin lymphoma (NHL) cell lines to the Aurora A inhibitor MK-8745 was increased when TPX2 was depleted with siRNA [86,87]. The gene discussed is TPX2; the disease is non-Hodgkin lymphoma.